Ignite Creation Date:
2025-12-24 @ 2:32 PM
Ignite Modification Date:
2026-05-26 @ 3:11 AM
Study NCT ID:
NCT02577159
Status:
UNKNOWN
Last Update Posted:
2018-08-29
First Post:
2015-08-11
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Dapagliflozin on Hyperlipidemia and Insulin Resistance in Type 2 Diabetic Patients (DAPHNIS Study)
Sponsor:
Osaka University
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Diabetes Mellitus, Type 2 | View |